Bone Biologics Corp - Warrants (13/10/2026)
BBLGW
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.84M
Close$
$2.19
71.5% downside
Current Fair Value
71.5% downsideOvervalued by 71.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.84 Million |
|---|---|
| Enterprise Value | $9.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.65 |
| Beta | 0.53 |
| Outstanding Shares | 1,796,755 |
Return
| Return on Equity | -73.66% |
|---|---|
| Return on Assets | -65.16% |
| Return on Invested Capital | -75.34% |
Valuation & Multiples
| P/E Ratio | -0.21 |
|---|---|
| PEG | -4.74 |
| Price to Sales | - |
| Price to Book Ratio | 3.85 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.87 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bone Biologics Corp
2 employees